Stocks · News reference
What's Going On With GlucoTrack Shares On Thursday?
GlucoTrack subsidiary Lokahi Therapeutics secured its first external fee-for-service partnership with nonprofit Innovate GBM for glioblastoma research.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Glucotrack, Inc. (GCTK)
Filed: 2026-09-28 AccNo: 0001493152-26-044657 Size: 334 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Glucotrack shares are trading lower. The company announced its subsidiary Lōkahi Therapeutics will partner with Pepperdine E2B to engage students in its ai2 Pipeline initiative during the upcoming academic year.
Glucotrack's Lōkahi Therapeutics Announces Partnership With Pepperdine Business School For MBA Students To Evaluate Drug Assets